Matches in Nanopublications for { ?s ?p "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP815839.RAe3jeYxeVpBIvUKu5Y7PGgY5-vc0JYz3dgXMGC5wNvkg130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815839.RAe3jeYxeVpBIvUKu5Y7PGgY5-vc0JYz3dgXMGC5wNvkg130_provenance.
- NP519273.RAC7e_6HwnrX261xMa3RlnlM40vqjti8vm-O7czV-4D4Y130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519273.RAC7e_6HwnrX261xMa3RlnlM40vqjti8vm-O7czV-4D4Y130_provenance.
- NP515500.RAmw05gML3YnX3BbzjBczLgMSmHSan4-dXyqZXe8icBuA130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515500.RAmw05gML3YnX3BbzjBczLgMSmHSan4-dXyqZXe8icBuA130_provenance.
- NP518875.RA2whv9b3CTjP3mBFRgI7MGWAIWf9xTvndZiK_WEmSPfA130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518875.RA2whv9b3CTjP3mBFRgI7MGWAIWf9xTvndZiK_WEmSPfA130_provenance.
- NP820490.RA7ubkRecJMZ8B5KJetnn_qKZYzKcsnfRL3wZtmt5Ncdo130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820490.RA7ubkRecJMZ8B5KJetnn_qKZYzKcsnfRL3wZtmt5Ncdo130_provenance.
- NP891195.RA6n50p0YcO6wmzuIzhC4Qc_9iAmPsNmEor9fUegTblak130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891195.RA6n50p0YcO6wmzuIzhC4Qc_9iAmPsNmEor9fUegTblak130_provenance.
- NP505190.RALnGKawosLpugAWzOKZFMfQm7-S9JoZmHrRlneiYfFBU130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505190.RALnGKawosLpugAWzOKZFMfQm7-S9JoZmHrRlneiYfFBU130_provenance.
- NP708133.RAJ972tA4NdeDCMPK9Y60IATtl5XM5JCmfb2XC32cDin0130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708133.RAJ972tA4NdeDCMPK9Y60IATtl5XM5JCmfb2XC32cDin0130_provenance.
- NP709290.RAJGN2ilSfVknvQgEFTviscCEtrJv0LEa5WUBTmdK1sms130_assertion description "[Focusing on ARID1A, we integrated mutation profiles with functional proteomics in 222 endometrial cancer samples, demonstrating that ARID1A mutations frequently co-occur with mutations in the phosphatidylinositol 3-kinase (PI3K) pathway and are associated with PI3K pathway activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709290.RAJGN2ilSfVknvQgEFTviscCEtrJv0LEa5WUBTmdK1sms130_provenance.